KOSSAN RUBBER INDUSTRIES BHD

KLSE (MYR): KOSSAN (7153)

You're accessing 15 mins delay data. Turn on live stream now to enjoy real-time data!

Last Price

1.82

Today's Change

0.00 (0.00%)

Day's Change

1.80 - 1.84

Trading Volume

3,375,800

Financial

Show?
Last 10 FY Result
AQR T4Q 31/12/23 31/12/22 31/12/21 31/12/20 31/12/19 31/12/18 31/12/17 31/12/16 31/12/15 31/12/14 CAGR
Revenue 1,763,058 1,685,158 1,585,878 2,316,228 6,657,487 3,653,514 2,221,607 2,144,235 1,957,445 1,667,996 1,639,509 1,301,740 2.21%
PBT 159,106 131,945 35,846 212,889 3,747,770 1,444,631 280,107 249,329 229,606 210,008 268,567 186,721 -16.74%
Tax -30,726 -24,364 -18,688 -53,581 -890,922 -352,019 -52,185 -44,029 -44,023 -38,960 -62,248 -37,885 -7.54%
NP 128,380 107,581 17,158 159,308 2,856,848 1,092,612 227,922 205,300 185,583 171,048 206,319 148,836 -21.32%
-
NP to SH 125,790 104,570 14,222 156,619 2,853,548 1,087,090 224,783 200,784 185,583 172,003 202,530 145,597 -22.76%
-
Tax Rate 19.31% 18.47% 52.13% 25.17% 23.77% 24.37% 18.63% 17.66% 19.17% 18.55% 23.18% 20.29% -
Total Cost 1,634,678 1,577,577 1,568,720 2,156,920 3,800,639 2,560,902 1,993,685 1,938,935 1,771,862 1,496,948 1,433,190 1,152,904 3.47%
-
Net Worth 3,852,435 3,852,435 3,839,167 3,883,565 4,032,672 2,380,611 1,419,618 1,291,725 1,151,042 104,234,019 946,412 799,393 19.03%
Dividend
AQR T4Q 31/12/23 31/12/22 31/12/21 31/12/20 31/12/19 31/12/18 31/12/17 31/12/16 31/12/15 31/12/14 CAGR
Div - 51,032 51,032 63,790 1,225,115 - - - - - 35,170 - -
Div Payout % - 48.80% 358.83% 40.73% 42.93% - - - - - 17.37% - -
Equity
AQR T4Q 31/12/23 31/12/22 31/12/21 31/12/20 31/12/19 31/12/18 31/12/17 31/12/16 31/12/15 31/12/14 CAGR
Net Worth 3,852,435 3,852,435 3,839,167 3,883,565 4,032,672 2,380,611 1,419,618 1,291,725 1,151,042 104,234,019 946,412 799,393 19.03%
NOSH 2,557,872 2,557,872 2,557,872 2,557,872 2,557,872 2,557,872 1,278,936 1,278,936 639,468 639,472 639,468 639,515 16.64%
Ratio Analysis
AQR T4Q 31/12/23 31/12/22 31/12/21 31/12/20 31/12/19 31/12/18 31/12/17 31/12/16 31/12/15 31/12/14 CAGR
NP Margin 7.28% 6.38% 1.08% 6.88% 42.91% 29.91% 10.26% 9.57% 9.48% 10.25% 12.58% 11.43% -
ROE 3.27% 2.71% 0.37% 4.03% 70.76% 45.66% 15.83% 15.54% 16.12% 0.17% 21.40% 18.21% -
Per Share
AQR T4Q 31/12/23 31/12/22 31/12/21 31/12/20 31/12/19 31/12/18 31/12/17 31/12/16 31/12/15 31/12/14 CAGR
RPS 69.10 66.04 62.15 90.77 260.84 142.83 173.71 167.66 306.11 260.84 256.39 203.55 -12.34%
EPS 4.92 4.10 0.56 6.14 111.80 42.50 17.58 15.70 28.77 26.13 31.67 22.77 -33.73%
DPS 0.00 2.00 2.00 2.50 48.00 0.00 0.00 0.00 0.00 0.00 5.50 0.00 -
NAPS 1.5098 1.5098 1.5046 1.522 1.58 0.9307 1.11 1.01 1.80 163.00 1.48 1.25 2.07%
Adjusted Per Share Value based on latest NOSH - 2,557,872
AQR T4Q 31/12/23 31/12/22 31/12/21 31/12/20 31/12/19 31/12/18 31/12/17 31/12/16 31/12/15 31/12/14 CAGR
RPS 68.93 65.88 62.00 90.55 260.27 142.83 86.85 83.83 76.53 65.21 64.10 50.89 2.21%
EPS 4.92 4.09 0.56 6.12 111.56 42.50 8.79 7.85 7.26 6.72 7.92 5.69 -22.69%
DPS 0.00 2.00 2.00 2.49 47.90 0.00 0.00 0.00 0.00 0.00 1.37 0.00 -
NAPS 1.5061 1.5061 1.5009 1.5183 1.5766 0.9307 0.555 0.505 0.45 40.7503 0.37 0.3125 19.03%
Price Multiplier on Financial Quarter End Date
AQR T4Q 31/12/23 31/12/22 31/12/21 31/12/20 31/12/19 31/12/18 31/12/17 31/12/16 31/12/15 31/12/14 CAGR
Date 28/06/24 28/06/24 29/12/23 30/12/22 31/12/21 31/12/20 31/12/19 31/12/18 29/12/17 30/12/16 31/12/15 31/12/14 -
Price 2.35 2.35 1.85 1.10 1.92 4.50 4.16 4.34 8.11 6.59 9.30 4.47 -
P/RPS 3.40 3.56 2.98 1.21 0.74 3.15 2.39 2.59 2.65 2.53 3.63 2.20 3.42%
P/EPS 47.67 57.34 331.92 17.92 1.72 10.59 23.67 27.64 27.94 24.50 29.36 19.63 36.89%
EY 2.10 1.74 0.30 5.58 58.23 9.44 4.22 3.62 3.58 4.08 3.41 5.09 -26.97%
DY 0.00 0.85 1.08 2.27 25.00 0.00 0.00 0.00 0.00 0.00 0.59 0.00 -
P/NAPS 1.56 1.56 1.23 0.72 1.22 4.84 3.75 4.30 4.51 0.04 6.28 3.58 -11.18%
Price Multiplier on Announcement Date
AQR T4Q 31/12/23 31/12/22 31/12/21 31/12/20 31/12/19 31/12/18 31/12/17 31/12/16 31/12/15 31/12/14 CAGR
Date 22/08/24 22/08/24 22/02/24 16/02/23 17/02/22 17/02/21 21/02/20 19/02/19 22/02/18 23/02/17 23/02/16 25/02/15 -
Price 2.04 2.04 2.02 1.13 1.69 4.01 4.65 4.00 8.70 6.48 6.75 5.50 -
P/RPS 2.95 3.09 3.25 1.24 0.65 2.81 2.68 2.39 2.84 2.48 2.63 2.70 2.08%
P/EPS 41.38 49.78 362.42 18.41 1.51 9.44 26.46 25.48 29.98 24.09 21.31 24.16 35.08%
EY 2.42 2.01 0.28 5.43 66.15 10.60 3.78 3.92 3.34 4.15 4.69 4.14 -25.85%
DY 0.00 0.98 0.99 2.21 28.40 0.00 0.00 0.00 0.00 0.00 0.81 0.00 -
P/NAPS 1.35 1.35 1.34 0.74 1.07 4.31 4.19 3.96 4.83 0.04 4.56 4.40 -12.36%

PBT = Profit before Tax, NP = Net Profit, NP to SH = Net Profit Attributable to Shareholder, Div = Dividend, NP Margin = Net Profit Margin, ROE = Return on Equity, NOSH = Number of Shares, RPS = Revenue per Share, EPS = Earning Per Share, DPS = Dividend Per Share, NAPS = Net Asset Per Share, EOQ = End of Quarter, ANN = Announcement, P/RPS = Price/Revenue per Share, P/EPS = Price/Earning per Share, P/NAPS = Price/Net Asset per Share, EY = Earning Yield, DY = Dividend Yield.

NOSH is estimated based on the NP to SH and EPS. Div is an estimated figure based on the DPS and NOSH. Net Worth is an estimated figure based on the NAPS and NOSH.

Div Payout %, NP Margin, ROE, DY, QoQ & YoY figures in Percentage; RPS, EPS & DPS's figures in Cent; and NAPS's figures in Dollar.

All figures in '000 unless specified.

Discussions
19 people like this. Showing 50 of 16,088 comments

5231428

Looks very promising closing at high.

1 week ago

Epseps

The number fren, where n when is the QR please since repeated so many times. I trusted u tho

1 week ago

5231428

Let's see who will report QR first, Kossan or Supermax.

1 week ago

Gaussian

Clade I MPOX is much more dangerous and transmissible this time around. Unlike Clade II, Clade I can spread without sexual contact, making it much easier to transmit through skin-to-skin contact.

It is significantly more dangerous and contagious.

1 week ago

KimSua

Qtr high change out today afternoon. Looking for 2x increase in earnings q2q.

1 week ago

Chipee

Mpox will not be pandemic like Covid.. and we want that. If it's a pandemic, US might delay the tariff on China. This will strengthen CHina glove financially. We want Mpox not a pandemic and US implement their tariff on China gloves as soon as possible.

1 week ago

Gaussian

Mpox is going to be worse than Covid pandemic because of the incubation period 21 days lol

1 week ago

Chipee

Mpox is not air-borne virus. Mpox will not be a pandemic.

1 week ago

Gaussian

Countries across Asia are increasing surveillance and countermeasures against mpox as Thailand reported its first suspected case of a new, more dangerous variant of the virus.

South Korea said that epidemiologists and public health doctors will be deployed at the gates of flights arriving from Ethiopia to monitor incoming passengers.

Anyone with mpox symptoms will be required to report to quarantine officers on arrival.

Waste from aircraft toilets will also be monitored for the virus.

Source: Telegraph

1 week ago

Gaussian

Everyone will be in the dark and expose to the virus for 21 days. lol

1 week ago

Albukhary

QR boom...
50% lower than my expectation of RM60mil PAT.

1 week ago

Chipee

I was expecting Rm75 mill ... 😁 .. Now wait for USTR announcement..sigh

1 week ago

Chipee

I think their ASP is $16 still. Can't believe it. Even Sri Thang ASP is $18.

1 week ago

Albukhary

But don't worry, I believe revenue drop could be highly due to the Red Sea crisis and cause some of the June'24 sales postpone to July'24.

If this is the case, then you can expect next quarter Q3'2024 to achieve PAT of minimum RM70-80mil (assume at least RM10mil profit brought forward from Q2 to Q3)

1 week ago

Chipee

I hope you're right Albukhary. With this QR result it could go either way. Just bcoz Harta QR was excellent. Kossan is showing no improvement from previous qtr.

1 week ago

Endgame

31 mil profit, no wonder dropped from 2.5x to 2.0x

1 week ago

Patron

Harta PBT margin 7%
Kossan (gloves division) PBT margin 6.26%
and yes theres some shipment delays ( not sure how much , but harta had around 10% sales volume delay )

unless your expectation was not realistic if not its within the line

1 week ago

Chipee

Harta profit 31.9Mill .. price 2.75. What do you said abt that?

Endgame

31 mil profit, no wonder dropped from 2.5x to 2.0x

1 week ago

beginner888

Harta:

Mar’24 : Revenue 529.83mil
Mar’24 : PBT 18.88mil
Mar’24 : PBT Margin 3.6%

Jun’24 : Revenue 583.84mil
Jun’24 : PBT 41.14mil
Jun’24 : PBT Margin 7.0%



Kossan:

Mar’24 : Revenue 451.63mil
Mar’24 : PBT 40.98mil
Mar’24 : PBT Margin 9.0%

Jun’24 : Revenue 429.91mil
Jun’24 : PBT 38.57mil
Jun’24 : PBT Margin 9.0%

1 week ago

Mini2021

My expectation is 3 billion profit..... no woner drop to 2.0

1 week ago

Patron

@beginner888
for kossan you have to sort out the gloves division part
its 6.26% instead of 9.0%

1 week ago

Chipee

@Patron
"Sorting out glove division part" is like saying saying McD has to sort out the burger part from the fries part.
IF that's the case then Harta has to "sort out" their COAT gloves from the nitrile and latex gloves. Cmmon. Don't be ridiculous.

1 week ago

ChandranG

Analysts upgrade Kossan's ratings after 1H results meet expectations. Nice ~
https://theedgemalaysia.com/node/723968

1 week ago

KimSua

Have to hold longer, no concern next few qtrs, just no easy money, unless ustr pull in the tariffs to 2025. Or set it to 50 percent as propose

1 week ago

beginner888

@Patron noted. I missed your comment in the bracket (i.e., gloves division). Thank you for the reminder.

1 week ago

Patron

@Chipee
you know Kossan's non glove division for eg. Technical Rubber division contributed only 10% of the overall revenue but it contributed almost 30% of its PBT right ?

theres no right way to have 100% apple to apple comparison but we try to close the gap as much as possible to see the clearer picture

1 week ago

Patron

@beginner888
Harta & Kossan have similar PBT margin % if you exclude non cash / non operating cost like impairment , decommissioning cost , ramp up cost and etc.

its at 6-7% in Q2 - not too bad but not impressive enough. it all depends on upcoming sales order momentum.

1 week ago

Patron

@kimsua
USTR tariff will be implemented in 2026 - not too far away actually ( about 16 months away )
consider the long lead time and shipment time from China firms
probably the orders will come to Malaysia as soon as Q2 2025

1 week ago

beginner888

@Patron Thank you for providing those insights

1 week ago

KimSua

@patron the final ustr 301 determination has been delayed until the end of August. They are negotiating and getting feedback, one of the proposal is a 50 percent in medical ppe in 2025 while relaxing critical syringes tariffs. This is based after feedback from both medical associations and manufactures associations. Let's see how. Will scout around and published as soon as I can.

1 week ago

KimSua

Ops expenses reduce 430k to 409k. Trade receivable flat qtq but 30k higher than 2023. Red Sea is not really a big problem. Most expect better revenue. Best operating margin, well manage but can they manage the sales volume. If flat again next quarter, time to reasses. USTR should have a statement end of the week or next week

1 week ago

Patron

@kimsua
for Harta ,

Q2 sales volume at 5.9b
but 0.6b was delayed
it means 10% of the revenue was not recognized , which i think was quite serious especially the margin is at razor thin now

6 days ago

Patron

Q1 23 Q2 23 Q3 23 Q4 23 Q1 24 Q2 24
Harta's Sales volume (bil pieces) 5.7 4.3 4.6 4.5 5.6 5.9

Q3 is expected to be at 2.2b per month ( 6.6b per Qr)

volume is increasing but ASP is quite flattish i guess the industry wide is still facing oversupply issue but we are near to equilibrium as Harta / Kossan are no longer in losses anymore

demand < supply = losses
demand = supply = slight/zero profit
demand > supply = profit

its just part of the cycle

6 days ago

Fairus4469

Kossan mempunyai tunai yg paling banyak berbanding dengn Harta dan Top Glove?

5 days ago

Gaussian

The Global Strategic Preparedness and Response Plan (SPRP) for mpox, from September 2024 to February 2025, outlines urgent global actions to combat a new mpox outbreak declared a public health emergency. Focused on controlling human-to-human transmission, the plan emphasizes surveillance, research, and equitable access to medical tools, with an initial budget of $135 million.

5 days ago

Gaussian

The WHO is taking strong measures to stop the spread of Mpox. With only two confirmed cases of the more dangerous strain outside of Africa, they are already implementing a six-month readiness and preparedness program.

The WHO actions suggest an explosion of Mpox cases are imminent.

5 days ago

Chipee

We can only know the sales of glove due to mpox on Q3 result.

3 days ago

ChandranG

Indeed, the management will bring out the Mpox topic in the next briefing

3 days ago

SWT1988

m waiting below 1.65 b4 considering buying.

2 days ago

Chipee

Kenanga share got short kaw kaw ... hahaha ..
This IB always down play glove stock. Happy their stocks get trashed. The trashing will continue after the suspension. 😂
https://www.thestar.com.my/business/business-news/2024/08/29/bursa-malaysia-suspends-idss-for-kenanga-investment-bank

2 days ago

Chipee

More tariff is coming ... Canada. Hopefully they target on gloves too and EU follow suit.

https://insidetrade.com/trade/our-most-read-canada-targets-chinese-evs-steel-and-aluminum-hints-more-come

2 days ago

ChandranG

What goes around, come around. Your turn to get shorted, Kenanga 😁

2 days ago

Chipee

Yeah ... F them big time. 😂
ChandranG

What goes around, come around. Your turn to get shorted, Kenanga 😁

2 days ago

Endgame

Who collect Kossan in August, i wish to congratulate you all, because next month Sep is Kossan "party time", wait for it.

1 day ago

Endgame

Who sell one, i also hope you don't be sad, absolutely you're not entitled for this.

1 day ago

ket4212

kwap buying harta and topglove have something brewing

1 day ago

Post a Comment